Overweight with HBV infection limited the efficacy of TACE in hepatocellular carcinoma by inhibiting the upregulated HMGB1

BACKGROUND: Transarterial chemoembolization (TACE) is an effective treatment for patients with hepatocellular carcinoma (HCC). However, the impact of hepatitis B viral (HBV) infection and body mass index (BMI) on TACE is controversial. The present study aimed to compare the influence of HBV and high...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yuan-dong, Zhang, Hao, Chen, Ye-qiang, Wu, Chun-xue, Chen, Miao-ling, Xu, Hui-rong, Wang, Shuo, Liu, Jing-zhou, Han, Jian-jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480082/
https://www.ncbi.nlm.nih.gov/pubmed/34583662
http://dx.doi.org/10.1186/s12885-021-08783-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480082/
https://www.ncbi.nlm.nih.gov/pubmed/34583662
http://dx.doi.org/10.1186/s12885-021-08783-8

Ejemplares similares